A team of researchers at the University of California, Davis, made small tweaks to the molecular structure of lysergic acid diethylamide (LSD) to see if it could be turned into an effective ...
The work was led by David E. Olson, director of the Institute for Psychedelics and Neurotherapeutics at the University of California, Davis. Scientists in Olson’s lab and at Delix Therapeutics, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback